Anzeige
Mehr »
Login
Dienstag, 15.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Global Tactical tritt dem Critical Minerals Institute bei!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 08.04.2025

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
08.04.Blink Charging Co. Announces Notification from Nasdaq regarding late filing of Form 10-K111Bowie, MD., April 08, 2025 (GLOBE NEWSWIRE) -- Blink Charging Co.?(NASDAQ: BLNK) ("Blink" or the "Company"), a leading global owner, operator, provider, and manufacturer of electric vehicle (EV) charging...
► Artikel lesen
08.04.Victoria's Secret & Co. Announces Key Leadership Appointments to Drive Strategic Growth1.862New Brand Presidents to Lead Execution of Path to Potential Strategy, Building on Company's Strong Foundation to Usher in New Era of Innovation REYNOLDSBURG, Ohio, April 08, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen
08.04.Serina Therapeutics, Inc.: Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease52HUNTSVILLE, Ala., April 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. ("Serina") (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform drug...
► Artikel lesen
08.04.Lotus Technology Inc.: Lotus Technology Announces Management and Board Changes287NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Lotus Technology Inc. ("Lotus" or the "Company") (Nasdaq: LOT), a leading global intelligent and luxury mobility provider, today announced changes to its...
► Artikel lesen
08.04.Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to May 9, 202548New York, NY, April 08, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) ("Globalink" or the "Company"), a special purpose acquisition company, announced today...
► Artikel lesen
08.04.Audited results of Invalda INVL Group for 2024114Invalda INVL reported equity of EUR 222 million at the end of December 2024, or EUR 18.48 per share. These figures were 25.4% and 25.3% higher, respectively, than a year earlier, including the dividends...
► Artikel lesen
08.04.ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025391PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
08.04.Artiva Biotherapeutics, Inc.: Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer526SAN DIEGO, April 08, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies...
► Artikel lesen
08.04.Mama's Creations, Inc.: Mama's Creations Reports Fourth Quarter and Fiscal Year 2025 Financial Results91Fourth Quarter Revenues Increase 25.7% to $33.6 Million at 27.0% Gross Margin Profile Completion of Strategic CapEx Projects and New Senior Hires Driving Robust Revenue and Margin Growth EAST RUTHERFORD...
► Artikel lesen
08.04.Kura Sushi USA Announces Fiscal Second Quarter 2025 Financial Results519IRVINE, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. ("Kura Sushi" or the "Company") (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced financial...
► Artikel lesen
08.04.NeOnc Technologies Holdings, Inc.: NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy59CALABASAS, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous...
► Artikel lesen
08.04.Vincerx Pharma, Inc.: Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities87SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global...
► Artikel lesen
08.04.Annexon Biosciences: Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting168Oral Presentation Features Phase 3 Data Showing Rapid Recovery and Durable Benefit of Tanruprubart (formerly ANX005) on Clinically Meaningful Measures across Multiple Stages of GBS Disease Education...
► Artikel lesen
08.04.Nurix Therapeutics, Inc.: Nurix Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update139NX-5948 assigned the nonproprietary name "bexobrutideg"U.S. FDA Orphan Drug Designation granted to bexobrutideg for the treatment of Waldenström macroglobulinemiaAchieved $7M in milestones and a $15M...
► Artikel lesen
08.04.Inception Mining Inc. Announces Name Change to BluSky AI Inc.38Salt Lake City, Utah, April 08, 2025 (GLOBE NEWSWIRE) -- Inception Mining Inc. Announces Name Change to BluSky AI Inc. Salt Lake City, Utah - April 4, 2025-Inception Mining Inc. (OTCPink: BSAI), a...
► Artikel lesen
08.04.Nexus Industrial REIT Announces the Sale of Legacy Retail and Office Buildings and Leasing Update63OAKVILLE, Ontario, April 08, 2025 (GLOBE NEWSWIRE) -- Nexus Industrial REIT ("Nexus" or the "REIT") (TSX: NXR.UN) is pleased to announce the sale of its 50% ownership interest in 15 retail buildings...
► Artikel lesen
08.04.Magna International Inc. Announces Date for First Quarter 2025 Results Webcast325AURORA, Ontario, April 08, 2025)) MAGNA INTERNATIONAL INC. ANNOUNCES DATE FORFIRST QUARTER 2025 RESULTS WEBCAST FRIDAY, MAY 2nd, 2025 @ 8:00 AM EDT LIVE AUDIO WEBCASTWebcast registration:...
► Artikel lesen
08.04.Sanofi Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis413Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Results from the HERCULES phase 3 study showed delay in disability progression in...
► Artikel lesen
08.04.Société Générale announces results of the offer to purchase certain of its debt securities303SOCIETE GENERALE ANNOUNCES RESULTS OF THE OFFER TO PURCHASE CERTAIN OF ITS DEBT SECURITIES Press release Paris, April 8, 2025 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR...
► Artikel lesen
08.04.NP Digital Bolsters Its End-to-End Marketing Capabilities with the Acquisition of Yodel Mobile300The Global Digital Marketing Agency Enhances Its App Growth & User Acquisition CapabilitiesLONDON, April 08, 2025, a leader in end-to-end digital marketing, has announced a strategic agreement to acquire...
► Artikel lesen
Seite:  Weiter >>